These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26887520)

  • 41. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.
    Costa Rivas M; Huidobro Vence G; Fírvida Pérez JL; Campos Balea B; García Gonzalez J; Lázaro Quintela M; Caeiro Muñoz M; Taboada Valladares B; Castro Gómez JE; Vázquez Estevez S; Afonso Afonso FJ; Azpitarte Raposeiras C; Amenedo Gancedo M; Casal Rubio J
    Clin Transl Oncol; 2018 Nov; 20(11):1467-1473. PubMed ID: 29696478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose-escalation study of thoracic radiotherapy in combination with pemetrexed plus Cisplatin followed by pemetrexed consolidation therapy in Japanese patients with locally advanced nonsquamous non-small-cell lung cancer.
    Niho S; Kubota K; Nihei K; Sekine I; Sumi M; Sekiguchi R; Funai J; Enatsu S; Ohe Y; Tamura T
    Clin Lung Cancer; 2013 Jan; 14(1):62-9. PubMed ID: 22633219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study.
    Oshiro Y; Okumura T; Kurishima K; Homma S; Mizumoto M; Ishikawa H; Onizuka M; Sakai M; Goto Y; Hizawa N; Sato Y; Sakurai H
    J Radiat Res; 2014 Sep; 55(5):959-65. PubMed ID: 24864278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).
    Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH
    J Thorac Oncol; 2007 Sep; 2(9):831-7. PubMed ID: 17805061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
    Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
    Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT; Mehta P; Khan A; Marsh JC; Zusag TW; Warren WH; Fidler MJ; Abrams RA; Bonomi P; Liptay M; Faber LP
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):985-91. PubMed ID: 20932684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial.
    Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L
    JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.
    Brade A; MacRae R; Laurie SA; Bezjak A; Burkes R; Chu Q; Goffin JR; Cho J; Hope A; Sun A; Leighl N; Capobianco S; Feld R; Mahalingam E; Hossain A; Iscoe N; Shepherd FA
    Clin Lung Cancer; 2016 Mar; 17(2):133-41. PubMed ID: 26872764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS; Yoon SM; Choi EK; Yi BY; Kim JH; Ahn SD; Lee SW; Shin SS; Lee JS; Suh C; Kim SW; Kim DS; Kim WS; Park HJ; Park CI
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):76-81. PubMed ID: 15850905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
    Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
    Aydiner A; Sen F; Saglam EK; Oral EN; Eralp Y; Tas F; Toker A; Dilege S
    Clin Lung Cancer; 2011 Sep; 12(5):286-92. PubMed ID: 21729649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent chemoradiotherapy with cisplatin and S-1 or vinorelbine for patients with stage III unresectable non-small cell lung cancer: A retrospective study.
    Takase N; Hattori Y; Kiriu T; Itoh S; Kawa Y; Yamamoto M; Urata Y; Shimada T; Tsujino K; Soejima T; Negoro S; Satouchi M
    Respir Investig; 2016 Sep; 54(5):334-40. PubMed ID: 27566381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).
    Hida N; Okamoto H; Misumi Y; Sato A; Ishii M; Kashizaki F; Shimokawa T; Shimizu T; Watanabe K
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1625-31. PubMed ID: 22565592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.
    Walraven I; van den Heuvel M; van Diessen J; Schaake E; Uyterlinde W; Aerts J; Koppe F; Codrington H; Kunst P; Dieleman E; van de Vaart P; Verheij M; Belderbos J
    Radiother Oncol; 2016 Mar; 118(3):442-6. PubMed ID: 26900091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable, non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study.
    Saitoh J; Saito Y; Kazumoto T; Kudo S; Yoshida D; Ichikawa A; Sakai H; Kurimoto F; Kato S; Shibuya K
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1791-6. PubMed ID: 21601375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
    Yamaguchi M; Toyokawa G; Ohba T; Sasaki T; Kometani T; Hamatake M; Hirai F; Taguchi K; Yamanaka T; Seto T; Takenoyama M; Sugio K; Ichinose Y
    Ann Thorac Surg; 2013 Nov; 96(5):1783-9. PubMed ID: 23998404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533.
    Wozniak AJ; Moon J; Thomas CR; Kelly K; Mack PC; Gaspar LE; Raben D; Fitzgerald TJ; Pandya KJ; Gandara DR
    Clin Lung Cancer; 2015 Sep; 16(5):340-7. PubMed ID: 25703100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Mornex F; Peignaux K; Germain T; Wautot V; Chouaki N; Bourayou N; Tourani JM
    Lung Cancer; 2013 Apr; 80(1):68-74. PubMed ID: 23332163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.